1-4 of 4
zalcitabine
Close
Sort by
Journal Articles

Prohibitin Expression Level As a Companion Diagnostic Marker in Cytogenetically Normal Acute Myeloid Leukemia

Myung-Geun Shin, MD PhD, Moon James, BS, Jun Hyung Lee, MD MS, Hye-Ran Kim, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3933.
https://doi.org/10.1182/blood.V130.Suppl_1.3933.3933
Published: 2017
Journal Articles

Leveraging increased cytoplasmic nucleoside kinase activity to target mtDNA and oxidative phosphorylation in AML

Sanduni U. Liyanage, Rose Hurren, Veronique Voisin, Gaëlle Bridon, Xiaoming Wang, ChangJiang Xu, Neil MacLean, Thirushi P. Siriwardena, Marcela Gronda, Dana Yehudai, Shrivani Sriskanthadevan, Daina Avizonis, Aisha Shamas-Din, Mark D. Minden, Gary D. Bader, Rebecca Laposa, Aaron D. Schimmer
Journal: Blood
Blood (2017) 129 (19): 2657–2666.
https://doi.org/10.1182/blood-2016-10-741207
Published: 2017
Includes: Supplemental data
Journal Articles

Diagnostic and Prognostic Implications of Prohibitin Overexpression in Normal Karyotype Acute Myeloid Leukemia

Hye-Ran Kim, PhD, Jun Hyung Lee, MD, Min-Gu Kang, MD, Ra-Young Park, PhD, Moinul Md Hoque, B.S., Sol Jeong, B.S., Min-Seo Noh, B.S., Seok-Yong Choi, MD, PhD, Soo-Hyun Kim, MD, PhD, Jong-Hee Shin, MD, PhD, Soon-Pal Suh, MD, PhD, Myung-Geun Shin, MD, PhD
Journal: Blood
Blood (2016) 128 (22): 1714.
https://doi.org/10.1182/blood.V128.22.1714.1714
Published: 2016
Journal Articles

Leveraging Increased Nucleoside Kinase Activity to Selectively Deplete Mitochondrial DNA (mtDNA), Impair Oxidative Phosphorylation, and Target AML Cells

Sanduni U. Liyanage, Hon. B. Sc., Rose Hurren, Veronique Voisin, Wang Xiaoming, Gaëlle Bridon, Changjiang Xu, Neil MacLean, Thirushi Siriwardena, Aisha Shamas-Din, PhD, Shrivani Sriskanthadevan, Mark D. Minden, MD PhD, Gary D Bader, Rebecca Laposa, Aaron D. Schimmer, MD PhD
Journal: Blood
Blood (2016) 128 (22): 1573.
https://doi.org/10.1182/blood.V128.22.1573.1573
Published: 2016